EDGAR Filing Documents for 0001193125-10-008218

Form 8-K - Current report:

SEC Accession No. 0001193125-10-008218

Filing Date

2010-01-19

Accepted

2010-01-19 17:20:08

Documents

Period of Report

2010-01-13

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 8-K	d8k.htm	8-K	28001
2	LETTER AGREEMENT	dex11.htm	EX-1.1	87384
3	ARTICLES OF AMENDMENT TO AMENDED AND RESTATED ARTICLES OF INCORPORATION	dex31.htm	EX-3.1	64656
4	FORM OF COMMON STOCK PURCHASE WARRANT	dex41.htm	EX-4.1	66651
5	OPINION OF KARR TUTTLE CAMPBELL	dex51.htm	EX-5.1	13922
6	FORM OF SECURITIES PURCHASE AGREEMENT	dex101.htm	EX-10.1	147107
7	PRESS RELEASE	dex991.htm	EX-99.1	8649
8	GRAPHIC	g69880g11k59.jpg	GRAPHIC	20173
9	GRAPHIC	g69880g42h56.jpg	GRAPHIC	3527
10	GRAPHIC	g69880g80j66.jpg	GRAPHIC	5035
	Complete submission text file	0001193125-10-008218.txt		458146

Mailing Address 501 ELLIOTT AVE W STE 400 SEATTLE WA 98119

Business Address 501 ELLIOTT AVE W STE 400 SEATTLE WA 98119 2062707100

CELL THERAPEUTICS INC (Filer) CIK: 0000891293 (see all company filings)